What changed at MKM in January, and what the company will not say about it
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
API sourcing
Page 23 of 23 of this archive, newest first.
What a 38% rise in coupling-reagent prices does to a 30 mg vial
Follow the resin, not the catalogue.
Suzhou export categories for peptide intermediates were quietly renamed
Follow the resin, not the catalogue.
QYB declines, for the 13th time, to name its synthesis house
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
CPC declines, for the 14th time, to name its synthesis house
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
Suzhou export categories for peptide intermediates were quietly renamed
Follow the resin, not the catalogue.
What the paperwork is for, and who it was designed to protect
The header identifies the batch, the table records the tests, and the footer says who is answerable. Two of the three are usually incomplete.
What changed at CPC in January, and what the company will not say about it
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
Shenzhen export categories for peptide intermediates were quietly renamed
Follow the resin, not the catalogue.
Everything on the page, in the order a chemist would read it
Nothing on this page is difficult. It is simply unfamiliar, and unfamiliarity is what makes a weak certificate look like a strong one.
What changed at Homopeptide in January, and what the company will not say about it
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
What changed at GL Biochem in January, and what the company will not say about it
Documentation practice is the only part of vendor quality a buyer can assess before purchase.